Eustacchio S, Trummer M, Fuchs I, Schröttner O, Sutter B, Pendl G
Department of Neurosurgery, Karl-Franzens University, Graz, Austria.
Acta Neurochir Suppl. 2002;84:71-6. doi: 10.1007/978-3-7091-6117-3_8.
Microsurgical excision with preservation of juxtaposed neurovascular structures is considered the treatment of choice for skull base meningiomas, but there exists a great controversy regarding surgical resectability, potential risk for subsequent postoperative Cranial Nerve Deficit (CND) and the role of adjuvant or adjunctive treatment options. In this study we evaluated the effect of Gamma Knife Radiosurgery (GKRS) in 121 patients with benign basal meningiomas after a follow-up of 5 to 9.8 years.
Sixty patients had undergone open resections prior to radiosurgical treatment and 61 patients were treated by GKRS alone. Tumour volumes of 0.5 to 89.9 ccm (median 6.8 ccm) received a median marginal dose of 13 Gy (range 7-25 Gy) at the covering 25% to 80% isodose volume curves (median 45%).
Neuroradiological controls demonstrated decreased tumour size in 73 patients (60.3%), stable meningioma volume in 47 cases (38.9%) and tumour enlargement in one patient (0.8%). Clinically, 54 patients (44.6%) improved and 61 cases (50.4%) remained unchanged. Four patients (3.3%) showed temporary and two patients (1.7%) permanent neurological deterioration (unrelated to tumour or treatment in one patient). Two patients (1.7%) developed radiation induced new or aggravated pre-existent CND (1 transient, 1 permanent) and two patients (1.7%) required further surgical resection.
In our long-term experience, GKRS proved to be an attractive additional and save alternative primary treatment option in selected patients with basal meningiomas. The tumour control rate of 98.3% associated with excellent clinical outcome and low incidence for treatment related CND (1.7%) compares favourably with the reported microsurgical series.
保留毗邻神经血管结构的显微手术切除被认为是颅底脑膜瘤的首选治疗方法,但在手术可切除性、术后继发颅神经缺损(CND)的潜在风险以及辅助或附加治疗方案的作用方面存在很大争议。在本研究中,我们对121例良性基底脑膜瘤患者进行了5至9.8年的随访,评估了伽玛刀放射外科(GKRS)的疗效。
60例患者在接受放射外科治疗前接受了开放性切除术,61例患者仅接受了GKRS治疗。肿瘤体积为0.5至89.9立方厘米(中位数6.8立方厘米),在覆盖25%至80%等剂量体积曲线(中位数45%)时接受的中位边缘剂量为13 Gy(范围7 - 25 Gy)。
神经放射学检查显示,73例患者(60.3%)肿瘤体积缩小,47例患者(38.9%)脑膜瘤体积稳定,1例患者(0.8%)肿瘤增大。临床上,54例患者(44.6%)病情改善,61例患者(50.4%)病情无变化。4例患者(3.3%)出现暂时神经功能恶化,2例患者(1.7%)出现永久性神经功能恶化(1例与肿瘤或治疗无关)。2例患者(1.7%)发生放射性诱导的新的或加重的既往CND(1例短暂性,1例永久性),2例患者(1.7%)需要进一步手术切除。
根据我们的长期经验,GKRS被证明是选定的基底脑膜瘤患者有吸引力的额外且安全的替代主要治疗选择。98.3%的肿瘤控制率与良好的临床结果以及低治疗相关CND发生率(1.7%)与报道的显微手术系列相比具有优势。